Potential role for rFVIIa in transfusion medicine

被引:173
作者
Hedner, U [1 ]
Erhardtsen, E [1 ]
机构
[1] Novo Nordisk AS, Res & Dev, DK-2880 Bagsvaerd, Denmark
关键词
D O I
10.1046/j.1537-2995.2002.00017.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:114 / 124
页数:11
相关论文
共 85 条
  • [1] ABERG M, 1978, ANN SURG, V189, P243
  • [2] ALTERATIONS IN COAGULATION AND FIBRINOLYTIC MECHANISMS IN ACUTE TRAUMA
    ATTAR, S
    BOYD, D
    LAYNE, E
    MCLAUGHLIN, J
    MANSBERGER, AR
    COWLEY, RA
    [J]. JOURNAL OF TRAUMA, 1969, 9 (11): : 939 - +
  • [3] EXPRESSION OF TISSUE FACTOR PROCOAGULANT ACTIVITY - REGULATION BY CYTOSOLIC CALCIUM
    BACH, R
    RIFKIN, DB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (18) : 6995 - 6999
  • [4] PURIFICATION AND CHARACTERIZATION OF TAFI, A THROMBIN-ACTIVABLE FIBRINOLYSIS INHIBITOR
    BAJZAR, L
    MANUEL, R
    NESHEIM, ME
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (24) : 14477 - 14484
  • [5] BAUER KA, 1990, BLOOD, V76, P731
  • [6] BECH R, 1989, THROMB HAEMOSTASIS, V62, P55
  • [7] Beguin S, 1997, THROMB HAEMOSTASIS, V78, P590
  • [8] BEGUIN S, 1989, THROMB HAEMOSTASIS, V61, P25
  • [9] Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: A preliminary study
    Bernstein, DE
    Jeffers, L
    Erhardtsen, E
    Reddy, KR
    Glazer, S
    Squiban, P
    Bech, R
    Hedner, U
    Schiff, ER
    [J]. GASTROENTEROLOGY, 1997, 113 (06) : 1930 - 1937
  • [10] NovoSeven® in warfarin-treated patients
    Berntorp, E
    Stigendal, L
    Lethagen, S
    Olofsson, L
    Hedner, U
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 : S113 - S115